GlassScriptPhysician profile
Kevin W Choy
NPI 1174731285
$4,033.33
in general payments reported to CMS, 2019-2025
20 companies · $547 in 2025
The $547 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,547 · 2020: $317 · 2021: $553 · 2022: $193 · 2023: $420 · 2024: $456 · 2025: $547.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,422.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $744.58 | 2019-2025 | Unity, Clareon, Rocklatan |
| Aerie Pharmaceuticals, INC. | $632.84 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $500.41 | 2019-2021 | |
| Allergan, INC. | $431.96 | 2019-2021 | |
| Glaukos Corporation | $360.99 | 2019-2023 | Iaccess Precision Blade |
| Shockwave Medical, INC | $270.22 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbvie INC. | $150.63 | 2023-2025 | Alphagan P, Lumigan, Vuity |
| Mallinckrodt Hospital Products INC. | $145.22 | 2022-2023 | Acthar |
| Eyepoint US, INC. | $133.08 | 2019 | |
| Bausch & Lomb Americas INC. | $103.71 | 2024 | Xiidra, Miebo |
| Stryker Corporation | $92.28 | 2025 | Artix Mt, Flowtriever |
| Shire North American Group INC | $91.83 | 2019 | |
| Horizon Therapeutics Plc | $87.42 | 2022-2023 | Tepezza |
| Novartis Pharmaceuticals Corporation | $66.89 | 2019-2022 | |
| Biotissue Holdings INC. | $51.15 | 2019-2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyevance Pharmaceuticals LLC | $49.50 | 2019-2022 | |
| Thea Pharma INC. | $42.04 | 2022-2023 | |
| Sun Pharmaceutical Industries INC. | $36.03 | 2025 | |
| Abiomed | $23.09 | 2024 | Impella |
| Oyster Point Pharma, INC. | $19.46 | 2023 | Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Choy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.